Mermaid Medical Group® Announces UKCA Approval for the Advanced TP Pivot Pro™
With its recent UKCA approval, Mermaid Medical is ready to introduce the TP Pivot Pro™ to UK healthcare professionals.
Welcoming Marcus Kildegaard Nielsen as Sales Director for Mermaid Medical
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024.
Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Throughout his time with Mermaid Medical, Marcus has held various positions, and we are thrilled to announce his new role as Sales Director. His valuable contributions across sales, marketing, and management have showcased a broad and diverse skill set. Marcus has excelled in various projects, from leading product management in the endovascular field to overseeing both direct and indirect global markets.
In his new role, Marcus will be responsible for managing all global sales initiatives across our subsidiaries in Europe and the US. Additionally, he will continue as General Manager for Mermaid Medical, Inc. in the US and remain a non-executive board member of Mermaid Medical Group.
Furthermore, Marcus is joining the Commercial Excellence Board to support the company’s business development efforts. This underscores Mermaid Medical’s ongoing investment in leadership, ensuring that we deliver exceptional clinical support, foster strong partner collaborations, and provide essential medical devices.
With Marcus’ strategic industry insights, goal-oriented mindset, and visionary leadership, we are confident he will enhance our sales operations and drive overall business success.
ISO 14001 Certified: Small (Action) Steps Toward a Greener Future
2024 marks a significant milestone in our journey toward sustainability - we achieved ISO 14001 certification, underscoring our commitment to reducing our environmental footprint.
Mermaid Medical Group and Front Line Medical Technologies Inc. Announce Exclusive Distribution Agreement for REBOA Device
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.